
From Disruption to Agility: Resilient Strategies for Medtech in a Shifting Global Order
Join Accenture in this discussion about global tariff tensions and evolving FDA challenges—exacerbated by Department of Government Efficiency (DoGE) cost-cutting initiatives—are creating significant uncertainty for the MedTech industry.